Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours

Summary

This is a prospective, open-label, multicenter phase IV.II study. Patients with local relapse breast cancer will receive radiotherapy concomitant to the administration of capecitabine.

Timeline

Start

2007-09

Primary completion

2009-01

Completion

2009-01

Outcome

Outcome not reported

Stopped (Enrollment): “Due to the slow rate of recruitment the study was stopped.”

Drugs

Indications